Patent details

Basic Information

Publication number:

EP2480084

PCT Application Number:

PCT/US/2010/049946

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP108194358

PCT Publication Number:

WO/2011/038082

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMBINATION

French Title of Invention:

COMBINAISON PHARMACEUTIQUE

German Title of Invention:

PHARMAZEUTISCHE KOMBINATION

SPC Number:

Dates

Filing date:

23/09/2010

Grant date:

12/11/2014

EP Publication Date:

12/11/2014

PCT Publication Date:

31/03/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/08/2012

EP B1 Publication Date:

12/11/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/09/2016

Expiration date:

23/09/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/08/2015

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

GILMER Tona

Address:

United States (US)

2

Name:

LEBOWITZ Peter, F.

Address:

United States (US)

3

Name:

LAQUERRE Sylvie

Address:

United States (US)

4

Name:

MORRIS Shannon, Renae

Address:

United States (US)

5

Name:

KUMAR Rakesh

Address:

United States (US)

6

Name:

DUMBLE Melissa

Address:

United States (US)

Priority

Priority Number:

245019 P

Priority Date:

23/09/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4155;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

14/09/2015

Last Annual Fee Paid Number:

6

Last Annual Fee Paid Amount:

66 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages